de cotation: Londres
The Group's principal
activity is developing, marketing and distributing pharmaceutical
The Group offers a range of 34 acquired and licensed, prescription
across a range of therapeutic categories, including dermatology,
the prevention of heart disease, nutrition and in the treatment of
disease. Brands are Nu-Seals, Forceval, Hydromal, Syntocinon,
Deltacortril, Syntometrine, Naseptin, Atarax and Periostat.